Predictive Technology Group, Inc. (PRED)
| Market Cap | 1.05M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 299.60M |
| EPS (ttm) | -0.23 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,000 |
| Open | 0.0035 |
| Previous Close | 0.0035 |
| Day's Range | 0.0035 - 0.0035 |
| 52-Week Range | 0.0004 - 0.5650 |
| Beta | 0.21 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About PRED
Predictive Technology Group, Inc., together with its subsidiaries, develops and commercializes discoveries and technologies involved in novel molecular diagnostic, therapeutic, and human cellular and tissue-based products (HCT/Ps). It operates in two segments, Human Cellular and Tissues Products (HCT/Ps); and Diagnostics and Therapeutics. The company provides FertilityDX, a genetic testing service for couples experiencing infertility; ARTguide, a genetic test for women experiencing infertility because of endometriosis and other genetic conditio... [Read more...]
News
Called to Account: SEC halts trading in two stocks amid claims about COVID-19 tests
Shares of two companies that a short seller alleged were making fraudulent claims about tests for COVID-19 were suspended from trading by the Securities and Exchange Commission on Wednesday, as the regu...